Pneumagen develops glycan targeted carbohydrate binding modules (CBMs) for respiratory tract infections ) and cancer.

Biotechnology

Health & Wellness

Health Care

Pneumagen

Pneumagen's headquarters in Saint Andrews, United Kingdom

David Brady

Mark R. Bamforth

Garry Taylor

Thomas Engelen

Jürgen Haas

John Skehel

Richard Webby

Moira Whyte

The Scientific Research Team at Pneumagen focuses on advancing the development of glycan-targeted carbohydrate binding modules (CBMs) to combat respiratory tract infections and cancer. Comprising senior scientists and esteemed scientific advisory board members, the team conducts cutting-edge research, evaluates novel therapeutic approaches, and collaborates on preclinical studies to optimize the efficacy and safety of these innovative treatments.

Scientific Research Team

This department oversees the strategic direction and governance of the organization.

Executive Leadership

This department focuses on driving innovation through research initiatives and fostering strategic partnerships to support business growth.

Research and Business Development

This department oversees the planning and execution of clinical projects and medical initiatives.

Pneumagen

Org chart

Board & advisors

Teams

Scientific Research Team

Executive Leadership

Research and Business Development

Clinical Operations

Offices

Pneumagen

Org chart

Board & advisors

Teams

Scientific Research Team

Executive Leadership

Research and Business Development

Clinical Operations

Offices

Related companies